Showing 531 - 540 of 1094 results

Showing Results for: “diabetes exercise”

American Diabetes Association® Applauds Colorado Governor and State Legislature for Passing HB 1216: Reduce Insulin Prices Bill

On May 22, 2019, Colorado Governor Jared Polis signed the first bill in the nation that will cap insulin co-pays at $100 per month, regardless of the number of vials needed. House Bill 1216: Reduce Insulin Prices, also enlists the Colorado Attorney General to investigate the rising price of insulin in Colorado and make recommendations to the General Assembly for further action. The American Diabetes Association (ADA) applauds Governor Polis and bill sponsors, Representative Dylan Roberts and Senators Kerry Donovan and Kevin Priola, for their leadership on this important legislation to reduce

Sadaf Farooqi, MB, ChB (Hons), PhD, Named American Diabetes Association’s® 2019 Outstanding Scientific Achievement Award

The American Diabetes Association® (ADA) will present the 2019 Outstanding Scientific Achievement Award (OSAA) to Sadaf Farooqi, MB, ChB (Hons), PhD. Dr. Farooqi will be recognized with this honor, which is given annually for research in diabetes that demonstrates particular independence of thought and originality, during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her OSAA Lecture, titled “ Obesity and the Biology of Weight Regulation ,” during the National Scientific and Health Care Achievement Awards Presentation

New Study Shows Hospitalization Rates for New Onset Pediatric Type 2 Diabetes Doubled During COVID-19 Pandemic

Initial data indicate that children presented with higher acuity compared to the previous year New data show that the incidence and acuity of type 2 diabetes in children increased significantly during the peak of the COVID-19 pandemic, with more pediatric patients hospitalized from March to December 2020 compared to the same time period in 2019. Findings from the retrospective chart review were presented as a late-breaking poster session at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Stay-at-home orders due to the COVID-19 pandemic exacerbated risk

American Diabetes Association Applauds Texas as it’s Added to Growing List of States Working to Reduce Cost-Sharing on Insulin

Texas becomes 19th state to sign vital legislation to help insulin costs for those with diabetes Today, the American Diabetes Association ® (ADA) applauded a major victory secured for people with diabetes in Texas as Governor Greg Abbott signed legislation yesterday that will help make insulin more affordable for Texans on state-regulated health plans. The new law, created by Senate Bill 827 and supported by the ADA, limits cost-sharing to $25 per prescription for a 30-day supply of insulin, regardless of the amount or type of insulin needed. With the signing of this bill, Texas becomes the

Study Finds Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in People with Type 1 and Type 2 Diabetes

Reduced hospitalization rates among people with low self-monitoring of blood glucose (SMBG) are especially pronounced People using Abbott’s FreeStyle Libre, a sensor-based glucose monitoring system, experienced a considerable decrease in ketoacidosis-related hospitalizations—52% for type 1 diabetes and 47% for type 2 diabetes—according to the study titled “Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study,” presented today at the American

FDA Expands Remote Patient Monitoring in Hospitals for People with Diabetes During COVID-19; Manufacturers Donate CGM Supplies

American Diabetes Association ® partners with Abbott to donate 25,000 CGM sensors to hospitals across the country Recently, the Food and Drug Administration (FDA) issued guidance to expand the availability and capability of non-invasive remote monitoring devices during the COVID-19 pandemic. This change was made in an effort to improve the ability of health care providers to monitor their patients while reducing their exposure to the novel coronavirus. The new policy will apply to non-invasive patient monitoring technology, including continuous glucose monitors (CGM), and expands their

American Diabetes Association® Applauds Illinois Governor and Legislature for Passing SB 667 to Cap Monthly Insulin Co-Pays

New legislation in Illinois to make insulin more affordable for all Illinoisans who need it Today, Illinois Governor J.B. Pritzker signed legislation that will cap insulin co-pays. Senate Bill 667 (SB 667) also requires the Illinois Department of Insurance to issue a report that includes a summary of insulin pricing practices as well as public policy recommendations to control and prevent overpricing of prescription insulin drugs made available to Illinois consumers. The American Diabetes Association (ADA) applauds Governor Pritzker and bill sponsors Senator Andy Manar and Representative Will